Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
432 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 28744 |
258 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 19509 |
2051 | 1 | FAS//FAS LIGAND//FASL | 2411 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FAS | authKW | 1076220 | 19% | 18% | 460 |
2 | FAS LIGAND | authKW | 953315 | 11% | 27% | 267 |
3 | FASL | authKW | 405593 | 5% | 24% | 129 |
4 | CD95 | authKW | 311932 | 5% | 20% | 119 |
5 | SOLUBLE FAS | authKW | 196924 | 1% | 42% | 36 |
6 | FAS ANTIGEN | authKW | 132856 | 2% | 27% | 38 |
7 | SOLUBLE FAS LIGAND | authKW | 121629 | 1% | 42% | 22 |
8 | CD95 LIGAND | authKW | 119182 | 1% | 40% | 23 |
9 | CD95L | authKW | 118358 | 1% | 36% | 25 |
10 | APO 1 | authKW | 112995 | 1% | 41% | 21 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 11133 | 33% | 0% | 795 |
2 | Oncology | 4841 | 25% | 0% | 592 |
3 | Cell Biology | 1420 | 14% | 0% | 340 |
4 | Medicine, Research & Experimental | 1332 | 10% | 0% | 238 |
5 | Hematology | 1308 | 8% | 0% | 188 |
6 | Pathology | 551 | 5% | 0% | 117 |
7 | Transplantation | 446 | 3% | 0% | 77 |
8 | Biochemistry & Molecular Biology | 412 | 15% | 0% | 365 |
9 | Rheumatology | 158 | 2% | 0% | 43 |
10 | Genetics & Heredity | 148 | 5% | 0% | 114 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCEROL MOL | 26141 | 0% | 100% | 2 |
2 | TUMOR IMMUNOL PROGRAM | 24163 | 1% | 8% | 24 |
3 | INTERNAL MED MOL CYTOL | 23524 | 0% | 60% | 3 |
4 | DEV MOL TARGET DRUGS | 22041 | 0% | 19% | 9 |
5 | MOL BIOL DIS | 17422 | 0% | 33% | 4 |
6 | ABT PATIATR HAMATOL ONKOL | 13070 | 0% | 100% | 1 |
7 | ADV DENT MED MALAYSIA MED CHEM | 13070 | 0% | 100% | 1 |
8 | AFFILIATED SHANGHAI CHANGZHENG HOSP | 13070 | 0% | 100% | 1 |
9 | AG EXP CHIR ONKOL | 13070 | 0% | 100% | 1 |
10 | BIOL CANC THER Y SURG ONCOL | 13070 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 7996 | 8% | 0% | 184 |
2 | CELL DEATH AND DIFFERENTIATION | 5949 | 2% | 1% | 39 |
3 | EUROPEAN JOURNAL OF IMMUNOLOGY | 5155 | 3% | 1% | 73 |
4 | INTERNATIONAL IMMUNOLOGY | 4135 | 1% | 1% | 36 |
5 | CELLULAR IMMUNOLOGY | 2597 | 2% | 1% | 40 |
6 | JOURNAL OF EXPERIMENTAL MEDICINE | 2155 | 2% | 0% | 46 |
7 | PEZCOLLER FOUNDATION SYMPOSIA | 1558 | 0% | 1% | 11 |
8 | BLOOD | 1345 | 3% | 0% | 62 |
9 | INTERNATIONAL JOURNAL OF CANCER | 1161 | 2% | 0% | 44 |
10 | IMMUNITY | 921 | 1% | 0% | 16 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FAS | 1076220 | 19% | 18% | 460 | Search FAS | Search FAS |
2 | FAS LIGAND | 953315 | 11% | 27% | 267 | Search FAS+LIGAND | Search FAS+LIGAND |
3 | FASL | 405593 | 5% | 24% | 129 | Search FASL | Search FASL |
4 | CD95 | 311932 | 5% | 20% | 119 | Search CD95 | Search CD95 |
5 | SOLUBLE FAS | 196924 | 1% | 42% | 36 | Search SOLUBLE+FAS | Search SOLUBLE+FAS |
6 | FAS ANTIGEN | 132856 | 2% | 27% | 38 | Search FAS+ANTIGEN | Search FAS+ANTIGEN |
7 | SOLUBLE FAS LIGAND | 121629 | 1% | 42% | 22 | Search SOLUBLE+FAS+LIGAND | Search SOLUBLE+FAS+LIGAND |
8 | CD95 LIGAND | 119182 | 1% | 40% | 23 | Search CD95+LIGAND | Search CD95+LIGAND |
9 | CD95L | 118358 | 1% | 36% | 25 | Search CD95L | Search CD95L |
10 | APO 1 | 112995 | 1% | 41% | 21 | Search APO+1 | Search APO+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |